These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28125999)

  • 41. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
    Guo R; Wu Q; Liu F; Wang Y
    Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.
    Hongdan L; Feng L
    Biochem Biophys Res Commun; 2018 Feb; 496(2):302-308. PubMed ID: 29307822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.
    Pietra G; Manzini C; Vitale M; Balsamo M; Ognio E; Boitano M; Queirolo P; Moretta L; Mingari MC
    Int Immunol; 2009 Jul; 21(7):793-801. PubMed ID: 19491215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bmi-1 is essential for the oncogenic potential in CD133(+) human laryngeal cancer cells.
    Wei X; He J; Wang J; Yang X; Ma B
    Tumour Biol; 2015 Nov; 36(11):8931-42. PubMed ID: 26081615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells.
    Liu YM; Li XF; Liu H; Wu XL
    Oncol Rep; 2015 Dec; 34(6):2977-86. PubMed ID: 26370320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transition from mesenchymal to bleb-based motility is predominantly exhibited by CD133-positive subpopulation of fibrosarcoma cells.
    Chikina AS; Rubtsova SN; Lomakina ME; Potashnikova DM; Vorobjev IA; Alexandrova AY
    Biol Cell; 2019 Oct; 111(10):245-261. PubMed ID: 31403697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression.
    Oricchio E; Sciamanna I; Beraldi R; Tolstonog GV; Schumann GG; Spadafora C
    Oncogene; 2007 Jun; 26(29):4226-33. PubMed ID: 17237820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.
    Lee SO; Yang X; Duan S; Tsai Y; Strojny LR; Keng P; Chen Y
    Oncotarget; 2016 Feb; 7(6):6626-38. PubMed ID: 26675547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.
    Kaur H; Ali SZ; Huey L; Hütt-Cabezas M; Taylor I; Mao XG; Weingart M; Chu Q; Rodriguez FJ; Eberhart CG; Raabe EH
    Cancer Lett; 2016 Jul; 377(1):55-64. PubMed ID: 27102002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
    Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
    Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy.
    Asadzadeh Z; Mansoori B; Mohammadi A; Kazemi T; Mokhtarzadeh A; Shanehbandi D; Hemmat N; Derakhshani A; Brunetti O; Safaei S; Aghajani M; Najafi S; Silvestris N; Baradaran B
    Biomed Pharmacother; 2021 May; 137():111364. PubMed ID: 33592546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients.
    Depil S; Roche C; Dussart P; Prin L
    Leukemia; 2002 Feb; 16(2):254-9. PubMed ID: 11840292
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation and identification of cancer stem-like cells from murine melanoma cell lines.
    Dou J; Pan M; Wen P; Li Y; Tang Q; Chu L; Zhao F; Jiang C; Hu W; Hu K; Gu N
    Cell Mol Immunol; 2007 Dec; 4(6):467-72. PubMed ID: 18163959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotypic Plasticity in Uveal Melanoma Is Not Restricted to a Tumor Subpopulation and Is Unrelated to Cancer Stem Cell Characteristics.
    Doherty RE; Sisley K; Hammond DW; Rennie IG; Cross NA
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5387-5395. PubMed ID: 29049740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.
    Mei D; Lv B; Chen B; Xiao S; Jiang J; Xie Y; Jiang L
    PLoS One; 2017; 12(8):e0182835. PubMed ID: 28817605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo.
    Zimmerer RM; Matthiesen P; Kreher F; Kampmann A; Spalthoff S; Jehn P; Bittermann G; Gellrich NC; Tavassol F
    Microvasc Res; 2016 Mar; 104():46-54. PubMed ID: 26656667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.